I

iBio
D

IBIO

2.51000
USD
0.03
(1.21%)
Market Closed
Volume
20
EPS
-8
Div Yield
-
P/E
-10
Market Cap
22,965,170
OverviewSignalsIdeasNews
Related Instruments
    A
    ABEO
    0.05000
    (0.89%)
    5.68000 USD
    A
    ABMD
    0
    (0%)
    0.000000 USD
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    ACRS
    -0.03500
    (-1.27%)
    2.73000 USD
    A
    ADAP
    0.00500
    (0.84%)
    0.59970 USD
    A
    ADC
    0.750
    (1.08%)
    70.210 USD
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    B
    BCLI
    0.23000
    (11.33%)
    2.26000 USD
    More
News

Title: iBio

Sector: Healthcare
Industry: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.